EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

COMPARATIVE EFFECTS OF CURCUMIN AND METFORMIN CO-THERAPY VERSUS METFORMIN ALONE IN DIABETIC NEUROPATHY

Atif Kaleem, Rabia Saleem

Axis Journal of Scientific Innovations · 30.09.2025 · 2 (2) · 19-27

DOI: 10.67129/2rc2wp61 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Axis Journal of Scientific Innovations, online erschienen am 30.09.2025. Verfasst von Atif Kaleem und 1 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic neuropathy is a major complication of diabetes mellitus characterized by progressive sensory loss and pain due to chronic hyperglycemia and oxidative stress. Metformin remains the standard antidiabetic therapy, but its effects on neuropathic complications are limited. Curcumin, a natural polyphenol with antioxidant and anti-inflammatory properties, has shown potential neuroprotective effects. Combining curcumin with metformin may provide synergistic benefits in mitigating neuropathic progression.

Objective

To determine whether curcumin supplementation enhances the neuroprotective efficacy of metformin in patients with diabetic neuropathy compared to metformin monotherapy.

Methods

A randomized controlled trial was conducted among 80 adults (aged 35–65 years) with type 2 diabetes and confirmed peripheral neuropathy in tertiary care hospitals of South Punjab. Participants were randomly assigned to receive either metformin alone (1000 mg twice daily) or metformin with curcumin (500 mg twice daily) for 16 weeks. Neuropathic symptoms were assessed using the Michigan Neuropathy Screening Instrument (MNSI) and Neuropathy Disability Score (NDS), while nerve conduction velocity (NCV), fasting blood glucose, glycated hemoglobin (HbA1c), malondialdehyde (MDA), and total antioxidant capacity (TAC) were measured pre- and post-intervention. Data were analyzed using paired and independent t-tests with a significance threshold of p < 0.05.

Results

Both groups showed improvement, but the combination group exhibited significantly greater reductions in MNSI (7.9 ± 1.2 to 4.9 ± 0.9) and NDS (5.7 ± 1.4 to 3.6 ± 1.0) scores, with marked increases in sural and peroneal NCV (p < 0.01). Curcumin co-therapy also resulted in superior glycemic control and reduced oxidative stress, reflected by decreased MDA and increased TAC levels.

Conclusion

Curcumin and metformin co-therapy demonstrated enhanced neuroprotective, metabolic, and antioxidant effects compared with metformin alone, suggesting a promising adjunctive approach for managing diabetic neuropathy.

Zitieren

APA

Kaleem, A., & Saleem, R. (2025). COMPARATIVE EFFECTS OF CURCUMIN AND METFORMIN CO-THERAPY VERSUS METFORMIN ALONE IN DIABETIC NEUROPATHY. Axis Journal of Scientific Innovations, 2(2), 19-27. https://doi.org/10.67129/2rc2wp61

Vancouver

Kaleem A, Saleem R. COMPARATIVE EFFECTS OF CURCUMIN AND METFORMIN CO-THERAPY VERSUS METFORMIN ALONE IN DIABETIC NEUROPATHY. Axis Journal of Scientific Innovations. 2025;2(2):19-27. doi:10.67129/2rc2wp61

BibTeX
@article{Kaleem2025,
  author = {Kaleem, Atif and Saleem, Rabia},
  title = {COMPARATIVE EFFECTS OF CURCUMIN AND METFORMIN CO-THERAPY VERSUS METFORMIN ALONE IN DIABETIC NEUROPATHY},
  journal = {Axis Journal of Scientific Innovations},
  year = {2025},
  volume = {2},
  number = {2},
  pages = {19--27},
  doi = {10.67129/2rc2wp61}
}
Kostenlos starten →